Cancer Treatment Centers of America® (CTCA) at Southwestern Regional Medical Center (Southwestern) uses advanced therapies and treatment options for patients with lung cancer and other lung diseases. The pulmonology team at CTCA® in Tulsa focuses on four primary areas of concern for lung cancer patients, including central airway obstruction, advanced airway diagnostics, pleural effusion and treatment-related side effects. When patients experience central airway obstructions, our pulmonologists may offer advanced and standard-of-care approaches to locate and clear the issue. CTCA at Southwestern uses a wide array of airway diagnostics to search for the cause of symptoms such as wheezing, coughing and labored breathing. Many people with lung cancer accumulate excess fluid around the lungs, called pleural effusion. Our hospital in Tulsa uses minimally invasive techniques to remove this fluid and restore more comfortable breathing. Some lung cancer treatments can cause side effects. The care team at CTCA offers various pulmonology procedures to treat symptoms, and to distinguish between a side effect of treatment and the progression of the cancer.
Dr. Daniel Nader leads the interventional pulmonology program (Lung Center) at CTCA at Southwestern. Dr. Nader, who has been with CTCA since 1991, has performed more than 6,500 bronchoscopy procedures and provided more than 1,700 high-dose rate (HDR) brachytherapy treatments. With access to recent advances in the diagnosis and treatment of lung cancer, Dr. Nader is dedicated to working with lung cancer patients to select a treatment plan customized to their needs.
The team of pulmonologists at the Tulsa cancer center provides patients a wealth of knowledge and experience. Using advanced therapies and technologies, the pulmonologists focus on locating and targeting tumors directly. This may reduce damage to healthy tissue near the tumor and reduce treatment-related side effects.